Adjuvant Anthracyclines and Taxanes: Quantifying the Costs of Therapeutic Advances in Breast Cancer

Publisher： Karger

E-ISSN： 2296-5262|32|8-9|464-466

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.32, Iss.8-9, 2009-07, pp. : 464-466

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Taxanes in adjuvant chemotherapy for early breast cancer

By Vincenzi Bruno   Santini Daniele   Tonini Giuseppe  

Women's Health, Vol. 2, Iss. 3, 2006-05 ,pp. : 323-325

Future Medicine

Access to resources Recommend Favorite

Adjuvant taxanes and the development of breast cancer‐related arm lymphoedema

By  

BRITISH JOURNAL OF SURGERY, Vol. 102, Iss. 9, 2015-08 ,pp. : 1071-1078

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Phase I Study of Capecitabine Combined with CPT-11 in Metastatic Breast Cancer Pretreated with Anthracyclines and Taxanes

By  

Oncology, Vol. 86, Iss. 4, 2014-05 ,pp. : 206-211

Karger

Access to resources Recommend Favorite

Gemcitabine plus Irinotecan in Breast Cancer Patients Pretreated with Taxanes and Anthracyclines: A Multicenter Phase II Study

By  

Oncology, Vol. 64, Iss. 4, 2003-05 ,pp. : 477-478

Karger

Access to resources Recommend Favorite

Gemcitabine plus Capecitabine Combination in Metastatic Breast Cancer Patients Previously Treated with Anthracyclines and Taxanes

By  

Oncology, Vol. 72, Iss. 5-6, 2008-01 ,pp. : 308-313

Karger

Access to resources Recommend Favorite